Anotherexample of selection bias occurs with induction therapy, correlates with IL-2 receptorantagonists, and a risk of renal dysfunction, and this medication is indicated forpatients at high risk for renal failure after transplantation26. This evidence concerns the gene IL2 and kidney failure.